跳至主要内容
临床试验/NCT01178723
NCT01178723Unknown不适用

The Effects of Breakfast Size on Hormonal Profile in Adults With Type 2 Diabetes Mellitus

Wolfson Medical Center2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2010年8月10日最近更新:
适应症

试验速览

阶段
不适用
入组人数
48
试验地点
2
主要终点
blood glucose balance

研究概览

简要总结

Studies has found a connection between breakfast consumption and obesity and obesity-related complications, but only few studies examined the effect of breakfast size.

The purpose of this study is to examine the effect of breakfast size on several parameters in adults with Type 2 diabetes mellitus.

详细描述

The prevalence of obesity has rapidly increased during recent decades, while the prevalence of skipping breakfast has increased.

Several studies have reported inverse relationships between the consumption of breakfast and BMI and weight gain. A study that examined the effect of breakfast size, found that an increased percentage of daily energy consumed at breakfast was associated with relatively lower weight gain. Preliminary results of clinical research (unpublished) show a connection between a large breakfast and weight loss and increased feeling of satiety throughout the day.

The purpose of this study is to examine the effect of breakfast size on blood glucose balance, and its correlation with hormonal profile (including appetite hormones), adipokines and pro-inflammatory cytokines, weight and body composition and lipid profile in adults with type 2 diabetes.

The study will use a randomized-controlled, non-blinded, prospective design, including 48 participants with type 2 diabetes, who are not insulin dependent.

The research group will receive instructions to eat a large breakfast compared with the control group that will receive instructions to eat a small breakfast.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women ages: 30-70
  • Type 2 diabetics who are treated on a diet and / or pills
  • Patients who receive a stable drug treatment (no change in the type/dosage of drugs during the three months preceding the research)
  • Obese or overweight (35> BMI> 25)
  • Patients who did not participate in another research for at least 30 days
  • Patients who agree to sign a consent form and participate in research
  • Patients with high compliance.

排除标准

  • Patients under the age 30 or over 70
  • Type 1 I diabetics
  • Patients who are insulin dependent
  • Type 2 diabetics who are treated with injections
  • BMI less than 25 or BMI over 35
  • Patients who had Bariatric surgery
  • Patients with food absorption disorders
  • Active malignant disease
  • Thyroid function disorder
  • Active psychiatric illness
  • Pregnancy / breastfeeding

结局指标

主要结局

blood glucose balance

时间窗: three months

HBA1C, C-peptid, insulin, glucose, HOMA-IR, Glycomark

次要结局

  • anthropometric parameters(three months)
  • Adipokines and hormones(three months)
  • pro-inflammatory cytokines(three months)
  • lipid profile(three months)

研究者

申办方类型
Other Gov

研究点 (2)

Loading locations...

相似试验